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Glycerylphosphorylcholine (GPC) concentration was reported to be elevated in renal medulla of experimental animals deprived of water. The activi- 
ties of GPC phosphodiesterases were similar in homogenates and membrane subfractions of renal cortex prepared from control, diuresis and antidi- 
uresis rats. There were no differences in these preparations’ ability to hydrolyze phosphorylcholine. In contrast, there was a nearly 50% reduction 
of non-specific phosphomonoesterase activity, usingp-nitrophenylphosphate as substrate and membrane subfractions prepared from the antidiure- 
sis animals. It is suggested that as a consequence, a pathway for the formation from L-a-glycerylphosphate is activated. 
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1. INTRODUCTION 
Glycerylphosphorylcholine (GPC) is generally believ- 
ed to be a metabolite derived from phosphatidylcholine 
as a result of phospholipase and lysophospholipase 
hydrolytic activities. Rat renal medulla homogenates ef- 
ficiently release free fatty acids from lecithin without 
the accumulation of lysophosphatidylcholine [ 11. Ro- 
dent tissues possess at least 2 phosphodiesterases for 
which GPC is a substrate. GPC choline phosphodi- 
esterase activity (EC 3.1.4.2) liberates free choline and 
L-a-glycerylphosphate and its presence has been well 
documented in several tissues including kidney [2,3]. 
The existence of an additional hydrolytic activity, 
originally detected in brain tissue, GPC phosphoryl- 
choline phosphodiesterase (EC 3.1.4.38) produces 
phosphorylcholine and glyceryl from GPC [4]. 
GPC concentration was found to be 80 times greater 
in the canine renal medulla than the renal cortex [5] and 
the GPC choline phosphodiesterase activity of a cortex 
homogenate was estimated to be 4-fold greater than 
that of a medulla homogenate [6]. The GPC concentra- 
tion was increased 1.5-fold in the renal medulla of rab- 
bits deprived of water for 24 h [7] and it was suggested 
that GPC may contribute to the maintenance of the in- 
tracellular osmotic balance of this tissue. The level of 
free choline was low in both the medulla and cortex 
while phosphorylcholine was undetectable. 
It seemed appropriate to determine if there were any 
alterations in the activities of both GPC phosphodi- 
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esterases in the renal medulla and cortex of control, an- 
tidiuresis and sucrose-induced iuresis rats. The phos- 
phomonoesterase activities towards p-nitrophenylphos- 
phate and phosphorylcholine were also estimated. 
2. MATERIALS AND METHODS 
[3H]Choline-labelled phosphatidylcholine was purchased from 
NEN (Boston, MA, USA) and diluted with non-radioactive phos- 
phatidylcholine to a final specific activity of about 
3 X 10’ cpm//mol. This was saponified to provide [3H]choline- 
labelled GPC according to a published method [8]. Phosphoryl[%]- 
choline was purchased from NEN (Boston, MA, USA) and diluted 
with the non-radioactive compound to a specific activity of about 
75 x lo5 cpm/‘mol. p-Nitrophenylphosphorylcholine was purchased 
from Sigma (St. Louis, MO, USA). 
Groups of 4-6 adult rats were either allowed access to water ad 
libitum as the control group, or deprived of water for 24-48 h as the 
antidiuresis group, or allowed access to 5% sucrose ad libitum for 
24-48 h as the diuresis group. The kidneys were removed, the medulla 
and cortex separated and pooled. Crude membrane subfractions were 
prepared from 10% homogenates in 0.32 M sucrose by centrifugation 
at 6000 x g for 10 min to obtain the PI pellet, at 17000 x g for 10 min 
to obtain the PZ pellet, and at 100000 x g for 1 h to obtain the Pr 
pellet. Duplicate samples of these homogenates and subcellular frac- 
tions containing about 10 pg protein were incubated with 2 mM [‘HI- 
GPC, 50 mM glycine pH 9.0 buffer in a final volume of 125 ,~l for 
1 h. [3H]Choline release from [3H]GPC was estimated directly accor- 
ding to the procedure of Fonum [9] and phospho(3H]choline after 
alkaline phosphatase treatment of the incubation mixtures to release 
free choline. The GPC phosphodiesterase activities were performed 
on 6 or 7 independent experiments and the values represent the 
averages of these results. Phosphorylcholine phosphomonoesterase 
activity was determined on duplicate samples of these homogenates 
and subcellular fractions containing about 10 gg protein and were in- 
cubated in 50 mM glycine buffer at pH 9.0 with 4 mM phosphoryl- 
[“Clcholine in a final volume of 125 pl for 1 h and the [‘4C]choline 
release estimated according to a published procedure 191. This activity 
was performed on 2 independent experiments and the values are the 
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average of these results. Non-specific phosphomonoesterase activity 
was determined on triplicate samples of these homogenates and sub- 
cellular fractions containing about 20 pg protein in incubations con- 
taining 10 mM p-nitrophenylphosphate in 50 mM glycine buffer pH 
9.0 in a final volume of 125 /Al for 1 hat 37°C. The release of p-nitro- 
phenol was measured spectrophotometrically at420 nm according to 
a published procedure [lo]. This enzyme activity was determined on 
3 independent experiments and the values presented are averages of 
these results. Proteins were estimated by a classical procedure [ 111. 
3. RESULTS 
3.1. GPC phosphodiesterases 
GPC phosphodiesterase activities were 2- to 3-fold 
greater in the renal cortex samples than for the cor- 
responding renal medulla samples. The activities of the 
Pz and P3 pellets were from 1 S- to 2.5fold greater than 
the whole homogenates. GPC choline phosphodi- 
esterase activity was 2- to 3-fold greater than the GPC 
phosphorylcholine phosphodiesterase activity for all 
samples (table 1). There were no apparent differences 
between any of the samples obtained from the control 
group as compared to the corresponding samples from 
Table 1 
GPC phosphodiesterase activities of renal cortex and medulla 
homogenates and membrane fractions from control, andidiuresis and 
sucrose-induced iuresis rat? 
GPC choline GPC phosphoryl- 
phospho- choline phospho- 
diesterase diesterase 
Control, cortex 
Whole homogenate 2.7 + 0.64 0.775 + 0.327 
PI pellet 2.4 + 0.41 0.750 + 0.218 
PZ pellet 5.05 + 1.38 1.46 + 0.49 
P3 pellet 5.8 IL 0.57 2.08 + 0.81 
Control, medulla 
Whole homogenate 1.07 f 0.53 0.36 rtO.18 
PI pellet 0.58 f 0.23 0.24 + 0.074 
P2 pellet 2.58 + 1.5 0.8 + 0.5 
P3 pellet 2.86 + 0.99 1.45 + 0.7 
Antidiuresis, cortex 
Whole homogenate 2.7 f 0.44 0.99 + 0.4 
P2 pellet 2.36 f 0.64 1.02 + 0.65 
P2 pellet 5.13 + 0.95 1.9 + 0.84 
P3 pellet 5.34 + 1.21 1.9 + 0.59 
Antidiuresis, medulla 
Whole homogenate 1.02 f 0.62 0.54 f 0.35 
PI pellet 0.6 k 0.36 0.20 + 0.09 
PZ pellet 2.58 k 1.83 0.96 + 0.35 
P3 pellet 2.75 + 1.55 0.849 k 0.48 
Sucrose-diuresis, cortex 
Whole homogenate 2.4 f 0.56 1.01 f 0.42 
PI pellet 2.81 i 1.22 1.35 * 0.55 
P2 pellet 5.31 * 1.91 1.26 + 0.33 
P3 pellet 5.21 + 1.3 1.04 + 0.42 
Sucrose-diuresis, medulla 
Whole homogenate 1.01 + 0.59 0.29 + 0.15 
PI pellet 0.94 * 0.7 0.086 + 0.037 
P2 pellet 3.01 k 2.16 0.47 + 0.35 
P3 pellet 2.08 + 0.942 0.51 * 0.33 
’ Activities expressed as pmol/mg protein per h 
the antidiuresis or the sucrose-induced iuresis groups 
except for the PI pellet of the control and the sucrose 
diuresis group. Levamesole, a phosphomonoesterase 
inhibitor, did not affect these GPC phosphodiesterase 
activities. 
3.2. Phosphoryl[‘4Jcholine hydrolysis 
The capacity to liberate free choline from phos- 
phorylcholine is equivalent for both the renal cortex 
and renal medulla. There is a 2- to 2.5fold higher ac- 
tivity in the PZ and P3 pellets compared to the original 
homogenates. There are no differences in the cor- 
responding activity between the two experimental 
groups and the controls (table 2). 
3.3. p-Nitrophenylphosphate hydrolysis 
There is little difference in non-specific phospho- 
monoesterase activity between the renal cortex and 
renal medulla samples. This activity is increased ap- 
proximately 2-fold in the PZ pellet and 3-fold in the P3 
pellet compared to the activity of the original homo- 
genates. There is an approximate 45% reduction in this 
Table 2 
Phosphomonoesterase activities of renal cortex and medulla 
homogenates and membrane fractions from control, antidiuresis and 
sucrose-induced iuresis rat? 
p-Nitrophenol 
releasedb 
Control, cortex 
Whole homogenate 5.67 + 1.23 
PI pellet 6.07 
P2 pellet 11.68 f 0.69 
P3 pellet 18.1 kO.32 
Control, medulla 
Whole homogenate 4.53 f 0.73 
Pr pellet 2.73 
P2 pellet 6.17 + 2.7 
P3 pellet 19.67 rt 0.17 
Antidiuresis, cortex 
Whole homogenate 5.83 + 0.98 
PI pellet 5.87 
P2 pellet 11.04 * 3.07 
P3 pellet 16.32 + 2.4 
Antidiuresis, medulla 
Whole homogenate 3.14 f 0.47 
PI pellet 1.51 
P2 pellet 6.11 + 1.33 
P3 pellet 10.14 + 2.99 
Sucrose-diuresis, cortex 
Whole homogenate 5.65 f 0.67 
Pr pellet 8.98 
P2 pellet 9.94 k 2.11 
P3 pellet 17.74 + 1.59 
Sucrose-diuresis, medulla 
Whole homogenate 4.36 + 0.83 
PI pellet 4.25 
P2 pellet 9.71 + 4.27 
P3 pellet 14.74 f 5.86 
a Activities expressed as pmol/mg protein per h 
b p-Nitrophenylphosphate as substrate 
’ Phosphoryl[r4]choline as substrate 
Choline 
released’ 
7.9 * 0.02 
5.28 + 2.7 
13.73 + 1.72 
21.75 + 4.52 
5.6 f 0.77 
2.78 + 1.42 
12.04 f 0.53 
17.0 k3.15 
7.61 k 2.2 
6.43 + 2.46 
13.0 + 2.6 
19.8 + 3.1 
5.59 + 0.9 
3.04 IL 0.65 
10.33 f 2.3 
13.33 + 5.33 
8.08 
12.29 
12.13 
18.43 
7.17 
7.12 
17.18 
16.07 
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phosphomonoesterase activity of the renal medulla 
homogenates and subfractions from the antidiuresis 
group compared to the controls. The level of 
significance for these was greater than 0.025,O.OOl and 
0.005 for the whole homogenate, the PZ pellet and the 
P3 pellet, respectively. There are no differences in the 
corresponding samples obtained from the renal cortex. 
4. DISCUSSION 
Previous estimates of in vitro hydrolysis of GPC by 
renal tissue homogenates have only examined the en- 
zyme responsible for choline release. Information on 
phosphorylcholine release had not been available. This 
may have been due to lack of appreciation of this en- 
zymatic activity in kidney since its original description 
indicated its exclusive localization in brain tissue. In ad- 
dition, it would be difficult to quantitate using a non- 
radioactive substrate. Estimations of GPC choline 
phosphodiesterase activity of renal tissue were based 
upon specific enzymatic quantitation of L-a-glyceryl- 
phosphate, the co-product [3]. Rat cortical homo- 
genates incubated with GPC were reported to produce 
equimolar amounts of glyceryl, inorganic phosphate 
and choline [ 121 with an activity of about 180 nmol/mg 
protein per h. This level of activity is approximately 
i6-fold lower than that presented in this report (table 
1). 
The differences of the GPC concentrations in renal 
cortex and medulla [7,12] cannot be explained due to a 
remarkable difference in these hydrolytic activities. 
Similarly, the observed elevation of GPC concentration 
in the medulla during antidiuresis 17,121 does not affect 
either of the GPC phosphodiesterase activities (table 1). 
The products of GPC phosphorylcholine diesterase ac- 
tivity are glyceryl and phosphorylcholine. This phos- 
phoester has been reported to be absent from the cor- 
tex, the medulla, the serum and urine of rats suggesting 
that this compound does not accumulate in kidney 
tissue and must be rapidly hydrolyzed [7]. There are no 
marked differences in phosphorylcholine phospho- 
monodiesterase activity of medulla or cortex in either 
the control or experimental groups (table 2). 
There was an appropriate 50% reduction of non- 
specific alkaline phosphatase activity of the homo- 
genate and the membrane pellets from the medulla, but 
not cortex, of the antidiuresis animals. Alkaline phos- 
phatase has been thought to hydrolyze a variety of 
phosphomonoesters, including phosphorylcholine [13]. 
This assumption appears incorrect since there was no 
reduction in the ability of medulla samples to hydrolyze 
phosphorylcholine but a 50% reduction in p-nitro- 
phenylphosphate hydrolysis. L-cr-glycerylphosphate, a 
product of GPC choline phosphodiesterase activity, is 
generally accepted to be a substrate for alkaline phos- 
phatase. Perhaps there is an accumulation of this phos- 
phomonoester as a consequence of reduced alkaline 
phosphatase activity. This could possibly cause a diver- 
sion of the normal catabolic pathway for cw-glyceryl- 
phosphate to the formation of GPC by a CDP-choline, 
sn-glyceryl-3 phosphate choline phosphotransferase 
[ 141. This in turn might contribute to the observed GPC 
elevation in the medulla of antidiuresis animals [7]. 
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